Collaborative Network

Replicor has established collaborations with renowned institutions to bring world class expertise to the testing and development of its NAP technology.

These institutions include:

Academic Medical Center (Amsterdam, the Netherlands)

Bangabandhu Sheikh Mujib Medical University (Dhaka, Bangladesh)

Baylor College of Medicine (Houston, Texas)

Centre National de Référence des Virus Influenza (Lyon, France)

CHUQ, Laval University (Québec, Canada)

Cincinnati Children’s Hospital (Cincinnati, Ohio)

Department of Medical Biophysics, University of Toronto (Toronto, Ontario)

Department of Virology, Technical University of Munich (Munich, Germany)

Hepatitis Viral Research Group, University of Adelaide (Adelaide, Australia)

INSERM U1052 (Lyon, France)

Institut National de la Recherche Scientifique – Institut Armand Frappier (Laval, Québec)

Institut National de Transfusion Sanguine (Paris, France)

Mt. Sinai School of Medicine (New York, New York)

National Microbiology Laboratory (Winnipeg, Manitoba)

New York Blood Center (New York, New York)

NIH / NIAID Antiviral testing program (Bethesda, Maryland)

NIH / NIDDK Liver Disease Institute (Bethesda, Maryland)

NIH / ACTG Aids Clinical Trials Group (Bethesda, Maryland)

Rocky Mountain Labs, NIH (Hamilton, Montana)

Southern Research Institute (Birmingham, Alabama)

University of Essen, Department of Virology (Essen-Duisberg, Germany)

University of Texas Medical Branch (Galveston, Texas)